These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30537258)

  • 1. An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome.
    Bakhtiari T; Ghaderi A; Safaee Nodehi SR; Aghazadeh Z; Tofighi Zavareh F; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
    J Cell Physiol; 2019 Aug; 234(8):12971-12977. PubMed ID: 30537258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
    Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effect of Mannuronic Acid as a Novel NSAID With Immunosuppressive Properties on Expression of SOCS1, SOCS3, SHIP1, and TRAF6 Genes and Serum Levels of IL-6 and TNF-α in Patients With Multiple Sclerosis.
    Najafi S; Saadat P; Beladi Moghadam N; Manoucherinia A; Aghazadeh Z; Vali Mohammadi A; Pashaiefar H; Hosseini M; Mirshafiey A
    J Clin Pharmacol; 2021 Oct; 61(10):1303-1310. PubMed ID: 33908653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-D-mannuronic Acid (M2000) and Inflammatory Cytokines in COVID-19; An In vitro Study.
    Robat-Jazi B; Ghorban K; Gholami M; Samizadeh E; Aghazadeh Z; Shahrbaf MA; Dadmanesh M; Hosseini Rouzbahani N; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):677-686. PubMed ID: 36640059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
    Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of β-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes' Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property.
    Taeb M; Jafarzadeh A; Mortazavi-Jahromi SS; Zainodini N; Mirzaei MR; Jafarnezhad-Ansariha F; Aghazadeh Z; Mirshafiey A
    Curr Drug Discov Technol; 2019; 16(3):265-271. PubMed ID: 29766814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
    Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
    Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
    Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
    Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Biology of β-D-mannuronic acid (M2000) on Human Dendritic Cell Based on MicroRNA-155 and MicroRNA-221.
    Tabrizian N; Fard NA; Farazmand A; Eftekhari R; Zavareh FT; Mirshafiey A
    Curr Drug Discov Technol; 2017; 14(1):53-58. PubMed ID: 27890012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Safety Property of β-D-Mannuronic Acid (M2000) as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells.
    Fard NA; Tabrizian N; Mirzaei R; Motamed N; Zavareh FT; Mirshafiey A
    Curr Drug Discov Technol; 2016; 13(3):164-169. PubMed ID: 27335103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
    Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
    Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-aging effects of M2000 (β-D-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model.
    Hosseini S; Abdollahi M; Azizi G; Fattahi MJ; Rastkari N; Zavareh FT; Aghazadeh Z; Mirshafiey A
    J Basic Clin Physiol Pharmacol; 2017 May; 28(3):249-255. PubMed ID: 28207414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of M2000 (β-D-Mannuronic acid) on TNF-α, IL-17 and FOXP3 gene expression in patients with inflammatory bowel disease.
    Mohammed HA; Saboor-Yaraghi AA; Vahedi H; Yekaninejad MS; Panahi G; Hemmasi G; Lakzaei M; Mirshafiey A
    Int Immunopharmacol; 2017 Oct; 51():107-113. PubMed ID: 28822915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
    Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
    Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
    Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-diabetic effect of
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Arch Physiol Biochem; 2019 Dec; 125(5):435-440. PubMed ID: 29882437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of β-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression.
    Mirshafiey A; Taeb M; Mortazavi-Jahromi SS; Jafarnezhad-Ansariha F; Rehm BHA; Esposito E; Cuzzocrea S; Matsuo H
    Pharmacol Rep; 2017 Oct; 69(5):1067-1072. PubMed ID: 28951072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
    Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A
    Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of β-D-mannuronic Acid, as a New Member of Non-steroidal Anti- Inflammatory Drugs Family, on the Expression Pattern of Chemokines and their Receptors in Rheumatoid Arthritis.
    Aslani M; Ahmadzadeh A; Aghazadeh Z; Zaki-Dizaji M; Sharifi L; Hosseini M; Mirshafiey A
    Curr Drug Discov Technol; 2021; 18(1):65-74. PubMed ID: 31657689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.